Anthem Biosciences Share Price

Anthem Biosciences Limited was originally incorporated as Anthem Biosciences Private Limited dated June 13 2006 issued by RoC. Subsequently Company was converted from a Private Company to a Public Company followed by the change in name of the Company to Anthem Biosciences Limited and a Certificate of Incorporation upon the conversion was issued by RoC on December 10 2024.The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation other organic compounds such as speciality organic molecules biologically active peptides etc. which are highvalue products used in drug agrochemical and speciality chemicals industries.The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions India Private Limited by acquiring 100 of its share capital in November 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in 201819. In year 2020 Company started operations to biological unit 2 earmarked for a specific client. It expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL. In FY 2024 Company set up a wholly owned subsidiary Neoanthem Lifesciences Private Limited and commenced operations at Unit III for development in projects. Company is planning an Offer for Sale by raising funds from public through IPO aggregating to Rs 3395 Cr Equity Shares..

Revenue: ₹550.03Cr as on September 2025 (Q2 FY26)
Net Profit: ₹173.43Cr as on September 2025 (Q2 FY26)
Listing date: 21 Jul, 2025
Chairperson Name: Ajay Bhardwaj